Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Human immunodeficiency virus (HIV)18.35M45.97%
Molecular Sample Management Solutions12.81M32.08%
Hepatitis C virus (HCV)3.23M8.09%
Coronavirus disease 2019 (COVID-19)2.16M5.40%
Risk assessment testing1.91M4.79%
Other product and service revenues1.2M3.00%
Non-product and services revenues263K0.66%
Molecular Services9K0.02%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States361.66M89.19%
Other regions35.7M8.80%
Europe8.11M2.00%
